Identification of a novel PRMD16::SKI fusion gene in T-prolymphocytic leukemia

The presence of the <i>PRDM16::SKI</i> fusion gene was described, for the first time, in a T prolymphocytic leukemia (T-PLL) patient with a long indolent period and a late development treatment requiring disease. The fusion transcript was detected by RNA sequencing and validated by reverse transcriptase polymerase chain reaction and Sanger/Cycle sequencing. The chimera occurs between exon 1 of the PR/SET Domain 16 (<i>PRDM16</i>) gene and exon 2 of the oncogene V-Ski Avian Sarcoma Viral Oncogene Homolog (<i>SKI</i>) gene. The finding provides insight into the role of genetic alterations, including fusion genes, in development and progression of T-PLL and may possibly lead to the development of effective and precise targeted therapy for this disease.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-08-26
DOI
https://doi.org/10.3389/fonc.2025.1658257
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification of a novel PRMD16::SKI fusion gene in T-prolymphocytic leukemia

Francesca Micci, Håkon Reikvam, Hilde Kollsete Gjelberg, Marta Brunetti
Frontiers in Oncology
Chronic Lymphocytic Leukemia Research
article

Identification of a novel PRMD16::SKI fusion gene in T-prolymphocytic leukemia

Francesca Micci, Håkon Reikvam, Hilde Kollsete Gjelberg, Marta Brunetti
article en

Abstract

The presence of the <i>PRDM16::SKI</i> fusion gene was described, for the first time, in a T prolymphocytic leukemia (T-PLL) patient with a long indolent period and a late development treatment requiring disease. The fusion transcript was detected by RNA sequencing and validated by reverse transcriptase polymerase chain reaction and Sanger/Cycle sequencing. The chimera occurs between exon 1 of the PR/SET Domain 16 (<i>PRDM16</i>) gene and exon 2 of the oncogene V-Ski Avian Sarcoma Viral Oncogene Homolog (<i>SKI</i>) gene. The finding provides insight into the role of genetic alterations, including fusion genes, in development and progression of T-PLL and may possibly lead to the development of effective and precise targeted therapy for this disease.

Frontiers in OncologyVol. 15
Haukeland University Hospital (NO), Norwegian Cancer Society (NO), University of Bergen (NO)
Openalex Percentile: Top 70%
Chronic Lymphocytic Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Identification of a novel PRMD16::SKI fusion gene in T-prolymphocytic leukemia — Francesca Micci, Håkon Reikvam, et al. · Frontiers in Oncology (2025) | TGRS Research Map | TGRS